In vitro and in vivo antifungal activities of the marine sponge constituent spongistatin

Robin Pettit, Tanja Woyke, Sandy Pon, Zbigniew Cichacz, George Pettit, Cherry L. Herald

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Spongistatin 1 is a macrocyclic lactone polyether from the marine sponge Hyrtios erecta. The aim of this study was to evaluate the in vitro and in vivo antifungal efficacies and mechanism of spongistatin 1. Spongistatin 1 was fungicidal for the majority of 74 reference strains and clinical isolates, including those resistant to flucytosine, ketoconazole or fluconazole, and retained activity in the presence of human serum or at lowered pH. The duration of the postantifungal effect following 1 h exposure to one, four and eight times the minimal inhibitory concentration was strain-dependent. Spongistatin 1 was significantly more efficacious than amphotericin B in reducing kidney infectious burden in a murine model of disseminated candidiasis, and reduced the lung burden in a murine model of pulmonary cryptococcosis. When cryptococcal microtubules were visualized by fluorescence microscopy and iterative deconvolution, spongistatin 1 was shown to disrupt first cytoplasmic and then spindle microtubules in a time- and concentration-dependent manner. Microtubule disruption was accompanied by an abnormal distribution of nuclei in budding cells and an inhibition of cell division, resulting in cells arrested in a large-budded stage. Spongistatin 1 should be pursued as a potential antifungal agent and as a probe to study major cellular processes.

Original languageEnglish (US)
Pages (from-to)453-463
Number of pages11
JournalMedical Mycology
Volume43
Issue number5
DOIs
StatePublished - Aug 2005

Fingerprint

Porifera
microtubules
animal models
lungs
flucytosine
Microtubules
ketoconazole
antifungal agents
fluconazole
candidiasis
amphotericin B
cell nucleus
fluorescence microscopy
lactones
cell division
kidneys
Flucytosine
Cryptococcosis
Lung
Ketoconazole

Keywords

  • Candida albicans
  • Cryptococcus neoformans
  • Hyrtios erecta
  • Microtubule
  • Postantifungal effect

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • veterinary(all)
  • Microbiology

Cite this

In vitro and in vivo antifungal activities of the marine sponge constituent spongistatin. / Pettit, Robin; Woyke, Tanja; Pon, Sandy; Cichacz, Zbigniew; Pettit, George; Herald, Cherry L.

In: Medical Mycology, Vol. 43, No. 5, 08.2005, p. 453-463.

Research output: Contribution to journalArticle

Pettit, Robin ; Woyke, Tanja ; Pon, Sandy ; Cichacz, Zbigniew ; Pettit, George ; Herald, Cherry L. / In vitro and in vivo antifungal activities of the marine sponge constituent spongistatin. In: Medical Mycology. 2005 ; Vol. 43, No. 5. pp. 453-463.
@article{fc7a8dce2ccc4e91a338f9df04f1f6c2,
title = "In vitro and in vivo antifungal activities of the marine sponge constituent spongistatin",
abstract = "Spongistatin 1 is a macrocyclic lactone polyether from the marine sponge Hyrtios erecta. The aim of this study was to evaluate the in vitro and in vivo antifungal efficacies and mechanism of spongistatin 1. Spongistatin 1 was fungicidal for the majority of 74 reference strains and clinical isolates, including those resistant to flucytosine, ketoconazole or fluconazole, and retained activity in the presence of human serum or at lowered pH. The duration of the postantifungal effect following 1 h exposure to one, four and eight times the minimal inhibitory concentration was strain-dependent. Spongistatin 1 was significantly more efficacious than amphotericin B in reducing kidney infectious burden in a murine model of disseminated candidiasis, and reduced the lung burden in a murine model of pulmonary cryptococcosis. When cryptococcal microtubules were visualized by fluorescence microscopy and iterative deconvolution, spongistatin 1 was shown to disrupt first cytoplasmic and then spindle microtubules in a time- and concentration-dependent manner. Microtubule disruption was accompanied by an abnormal distribution of nuclei in budding cells and an inhibition of cell division, resulting in cells arrested in a large-budded stage. Spongistatin 1 should be pursued as a potential antifungal agent and as a probe to study major cellular processes.",
keywords = "Candida albicans, Cryptococcus neoformans, Hyrtios erecta, Microtubule, Postantifungal effect",
author = "Robin Pettit and Tanja Woyke and Sandy Pon and Zbigniew Cichacz and George Pettit and Herald, {Cherry L.}",
year = "2005",
month = "8",
doi = "10.1080/13693780500050598",
language = "English (US)",
volume = "43",
pages = "453--463",
journal = "Medical Mycology",
issn = "1369-3786",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - In vitro and in vivo antifungal activities of the marine sponge constituent spongistatin

AU - Pettit, Robin

AU - Woyke, Tanja

AU - Pon, Sandy

AU - Cichacz, Zbigniew

AU - Pettit, George

AU - Herald, Cherry L.

PY - 2005/8

Y1 - 2005/8

N2 - Spongistatin 1 is a macrocyclic lactone polyether from the marine sponge Hyrtios erecta. The aim of this study was to evaluate the in vitro and in vivo antifungal efficacies and mechanism of spongistatin 1. Spongistatin 1 was fungicidal for the majority of 74 reference strains and clinical isolates, including those resistant to flucytosine, ketoconazole or fluconazole, and retained activity in the presence of human serum or at lowered pH. The duration of the postantifungal effect following 1 h exposure to one, four and eight times the minimal inhibitory concentration was strain-dependent. Spongistatin 1 was significantly more efficacious than amphotericin B in reducing kidney infectious burden in a murine model of disseminated candidiasis, and reduced the lung burden in a murine model of pulmonary cryptococcosis. When cryptococcal microtubules were visualized by fluorescence microscopy and iterative deconvolution, spongistatin 1 was shown to disrupt first cytoplasmic and then spindle microtubules in a time- and concentration-dependent manner. Microtubule disruption was accompanied by an abnormal distribution of nuclei in budding cells and an inhibition of cell division, resulting in cells arrested in a large-budded stage. Spongistatin 1 should be pursued as a potential antifungal agent and as a probe to study major cellular processes.

AB - Spongistatin 1 is a macrocyclic lactone polyether from the marine sponge Hyrtios erecta. The aim of this study was to evaluate the in vitro and in vivo antifungal efficacies and mechanism of spongistatin 1. Spongistatin 1 was fungicidal for the majority of 74 reference strains and clinical isolates, including those resistant to flucytosine, ketoconazole or fluconazole, and retained activity in the presence of human serum or at lowered pH. The duration of the postantifungal effect following 1 h exposure to one, four and eight times the minimal inhibitory concentration was strain-dependent. Spongistatin 1 was significantly more efficacious than amphotericin B in reducing kidney infectious burden in a murine model of disseminated candidiasis, and reduced the lung burden in a murine model of pulmonary cryptococcosis. When cryptococcal microtubules were visualized by fluorescence microscopy and iterative deconvolution, spongistatin 1 was shown to disrupt first cytoplasmic and then spindle microtubules in a time- and concentration-dependent manner. Microtubule disruption was accompanied by an abnormal distribution of nuclei in budding cells and an inhibition of cell division, resulting in cells arrested in a large-budded stage. Spongistatin 1 should be pursued as a potential antifungal agent and as a probe to study major cellular processes.

KW - Candida albicans

KW - Cryptococcus neoformans

KW - Hyrtios erecta

KW - Microtubule

KW - Postantifungal effect

UR - http://www.scopus.com/inward/record.url?scp=24644465514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24644465514&partnerID=8YFLogxK

U2 - 10.1080/13693780500050598

DO - 10.1080/13693780500050598

M3 - Article

VL - 43

SP - 453

EP - 463

JO - Medical Mycology

JF - Medical Mycology

SN - 1369-3786

IS - 5

ER -